New Research Suggests Coffee May Benefit Atrial Fibrillation Patients
People with irregular heartbeats, particularly those suffering from atrial fibrillation (AF), have often been told to cut back on caffeine. However, a recent study from the University of California, San Francisco indicates that moderate coffee consumption might actually help reduce the chances of AF returning after treatment.
The study involved 200 adults with persistent AF who were scheduled for a procedure called cardioversion, which aims to restore normal heart rhythm. Participants were randomly divided into two groups: one group continued to drink at least one cup of coffee daily, while the other group refrained from all caffeine for six months.
The main focus was to see how many participants experienced a recurrence of AF, monitored through electrocardiograms lasting at least 30 seconds. Researchers also tracked symptom severity and any negative side effects.
At the end of six months, 47% of the coffee drinkers experienced a recurrence of AF, compared to 64% of those who abstained from caffeine. This shows that those who kept drinking coffee had a 39% lower risk of AF returning. Both groups displayed similar side effects, indicating that moderate coffee consumption was generally well-received.
The findings indicate that avoiding coffee might not be necessary for those recovering from AF, and in fact, it could be helpful.
Dr. Gregory Marcus, an association chief of cardiology for research at UCSF Health, said, “We will now be seriously considering whether consuming caffeinated coffee might actually be a lifestyle factor that helps our atrial fibrillation patients.” He reassured those who cherish their coffee that it is safe to continue enjoying it.
However, further research is needed to solidify these results. Marcus noted that the initial findings can only apply to people who regularly drank coffee before the study. Those who felt that caffeine might trigger their AF were not included, which could limit the comprehensiveness of the results.
The study was classified as “open-label,” meaning both participants and researchers knew who was in which group. This might introduce some bias since expectations about caffeine could influence how participants reported their symptoms.
Despite the promising results, researchers advise caution. They stress that the findings apply only to normal coffee consumption and not to energy drinks or high-dose caffeine products, which have shown the potential to trigger AF in some individuals.
Overall, this research offers a hopeful perspective for AF patients who enjoy their daily cup of coffee.
